Supporting information for Garber et al. (November 13, 2001) Proc. Natl. Acad. Sci. USA, 10.1073/pnas.241500798.

Table 1.

 Tumor grade, stage, and patient survival are listed for all patients in the three AC subgroups

Patient

Grade

Stage

Survival, months

Status

Adeno group 1-good prognosis

11-00

2

pT2pN0



12-00

2

pT1pN1



68-96

2

pT1pN0



132-95

3

pT1pN0

37

0

137-96

2

pT2pN0

32

0

156-96

1

pT2pN0

54+

0

180-96

2

pT1pN0

54+

0

181-96

2

pT4pN0 M1

25

1

187-96

2

pT1pN0

54+

0

198-96

2

pT1pN2

1

1

199-97

2

pT2pN1pM1

16

1

204-97

2

pT2pN2 M1

36

1

257-97

3

pT2pN2

2

1

313-99

3

pT2pN1pM1

17

1

319-00PT

2

pT1pN2pM1



320-00

3

pT2pN1pM1



Adeno group 2-good prognosis

165-96

2

pT1pN2 M1

18+

0

178-96

2

pT2pN0



185-96

2

pT1pN0 M0

54+

0

222-97

3

pT2pN2

48+

0

226-97

3

pT3pN2

48+

0

306-99

3

pT2pN1

24+

0

Adeno group 3-bad prognosis

59-96

3

pT2pN0 M1

11

1

80-96

3

pT2pN2 M1

3

1

139-96

3

pT3pN1pM1

5

1

184-96

2

pT2pN2 M1

3

1

218-97

3

pT2pN2

12

1

223-97

3

pT2pN2

5

1

234-97

3

pT2pN2pM1

0

1

265-98

2

pT1

15

1

319-00MT

3




Patient identification number is followed by the year in which the tumor was resected. Tumor grade and stage was determined by tumor morphology under the light microscope prior to microarray analysis. Grade 1 is well-differentiated tumor whereas grade 3 is poorly differentiated. Stage includes pT (tumor size), pN (lymph node metastasis), and pM (hematogenous metastasis). The prefix "p" stands for postsurgery (pathological) classification. Omitting the "p" indicates that this classification resulted from clinical data. Status refers to whether the patient is alive (indicated by 0), or died from either a tumor-related (indicated by a 1) or nontumor-related cause (indicated by 0). Patients that were alive at the time of clinical follow-up are indicated by +. Survival and status data are left blank for patients lost to follow-up or follow-up was less than 1 year.